Alpha DNA Investment Management’s Pentair PNR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-48
Closed -$2K 501
2021
Q1
$2K Buy
+48
New +$2.75K ﹤0.01% 577

Other funds holding PNR

Alpha DNA Investment Management's PNR Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Pentair (PNR) in Q2 2021, closing a stake of 48 shares — an estimated $2K sold.

Alpha DNA Investment Management first reported a position in PNR in Q1 2021 and held it in 1 quarter. The position peaked at $2K in Q1 2021. 518 funds tracked by Wall St. Rank hold PNR as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining Pentair position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 48 Pentair shares in Q2 2021, an estimated $2K.
  • Alpha DNA Investment Management first reported a position in Pentair in Q1 2021 and held it in 1 quarter.
  • Alpha DNA Investment Management's Pentair position peaked at $2K in Q1 2021.
  • 518 funds tracked by Wall St. Rank held Pentair as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.